Literature DB >> 1353103

Quantitation of human immunodeficiency virus provirus and circulating virus: relationship with immunologic parameters.

S Yerly1, E Chamot, B Hirschel, L H Perrin.   

Abstract

Virologic and seroimmunologic parameters were determined in 56 persons infected with human immunodeficiency virus (HIV). The provirus level varied from 10 to 100,000/10(6) CD4+ lymphocytes, and genomic HIV RNA was detectable in 39 of 56 patients at a relative concentration varying from 10 to greater than 250 copies/mL of serum. Provirus expressed as copies per 10(6) CD4+ lymphocytes and as circulating virus per milliliter of serum increased with disease progression and decrease of CD4+ cell concentration. The mean provirus concentration expressed per milliliter of blood varied little among categories of patients with various levels of CD4+ cells, but there was a progressive increase of circulating HIV genomic RNA. These virologic data suggest that during the course of HIV infection, an increasing proportion of the remaining CD4+ lymphocytes harbor the HIV genome and produce infectious virus. Finally, there was a marked correlation between increased provirus and genomic RNA concentration and three seroimmunologic markers: decrease in CD4+ cell count, p24 antigenemia, and disappearance of antibodies to HIV core antigen.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1353103     DOI: 10.1093/infdis/166.2.269

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  15 in total

1.  Comparison of the frequencies and levels of human immunodeficiency virus type 1 markers in specimens from chronically infected human T-lymphocyte cultures and from patients.

Authors:  D J Witt; C C Ginocchio; X P Wang; M K Kaufman
Journal:  Clin Diagn Lab Immunol       Date:  1999-05

Review 2.  AIDS and the lung: update 1995. 4. Role of the human immunodeficiency virus within the lung.

Authors:  J R Clarke; D S Robinson; R J Coker; R F Miller; D M Mitchell
Journal:  Thorax       Date:  1995-05       Impact factor: 9.139

3.  HIV-1 proviral DNA copy number in peripheral blood leucocytes and bronchoalveolar lavage cells of AIDS patients.

Authors:  J R Clarke; A J Gates; R J Coker; J A Douglass; J D Williamson; D M Mitchell
Journal:  Clin Exp Immunol       Date:  1994-05       Impact factor: 4.330

Review 4.  Use of virologic assays for detection of human immunodeficiency virus in clinical trials: recommendations of the AIDS Clinical Trials Group Virology Committee.

Authors:  S Hammer; C Crumpacker; R D'Aquila; B Jackson; J Lathey; D Livnat; P Reichelderfer
Journal:  J Clin Microbiol       Date:  1993-10       Impact factor: 5.948

Review 5.  Comparison of competitive and positive control-based PCR quantitative procedures coupled with end point detection.

Authors:  F Mallet
Journal:  Mol Biotechnol       Date:  2000-03       Impact factor: 2.695

6.  Low human immunodeficiency virus type 1 (HIV-1) DNA burden as a major cause for failure to detect HIV-1 DNA in clinical specimens by PCR.

Authors:  M Zazzi; L Romano; M Catucci; A De Milito; P Almi; A Gonnelli; M Rubino; P E Valensin
Journal:  J Clin Microbiol       Date:  1995-01       Impact factor: 5.948

7.  Quantitative molecular monitoring of human immunodeficiency virus type 1 activity during therapy with specific antiretroviral compounds.

Authors:  P Bagnarelli; S Menzo; A Valenza; S Paolucci; S Petroni; G Scalise; R Sampaolesi; A Manzin; P E Varaldo; M Clementi
Journal:  J Clin Microbiol       Date:  1995-01       Impact factor: 5.948

8.  Quantitation of human immunodeficiency virus type 1 DNA by two PCR procedures coupled with enzyme-linked oligosorbent assay.

Authors:  F Mallet; C Hebrard; J M Livrozet; O Lees; F Tron; J L Touraine; B Mandrand
Journal:  J Clin Microbiol       Date:  1995-12       Impact factor: 5.948

9.  Quantification of human immunodeficiency virus in plasma by RNA PCR, viral culture, and p24 antigen detection.

Authors:  I Van Kerckhoven; K Fransen; M Peeters; H De Beenhouwer; P Piot; G van der Groen
Journal:  J Clin Microbiol       Date:  1994-07       Impact factor: 5.948

10.  Epstein-Barr virus infection in HIV-positive patients.

Authors:  A Telenti; D E Uehlinger; F Marchesi; D Germann; R Malinverni; L Matter
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1993-08       Impact factor: 3.267

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.